DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

BSX Boston Scientific Corporation

Healthcare

Price
$42.19
Intrinsic value
$24.84
Buy price
$19.87
Discount
-69.8%
Overvalued

Live signals (1)

Daily bars as of Oct 8, 2026
  • FS-BullishFailure Swing (bullish)Bullish ↑

    Price undercut a recent swing low and closed back above it - the breakdown failed and trapped the sellers who chased it.

    Fired Oct 8, 2026on the latest daily bar37.4% win rate · 1.07x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)16.54%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$4,341,000,000.00
Total debt
$12,624,000,000.00
Cash & STI
$539,000,000.00
Shares out.
1,474,800,000
Overvalued
Intrinsic value$24.84
Buy price (with MOS)$19.87
Current price$42.19
Discount to intrinsic value-69.9%

7-step quality scorecard

ROE quality
LOW
Average ROE
8.2%
Current ROE
12.0%
Minimum ROE
4.0%
Debt quality
MODERATE
Debt / Equity
0.52x
Moat proxy
MODERATE_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.18x

Technical chart

Confluence: DOWNTREND (0/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
min(revenueCAGR,cfCAGR)
Valuation model
DCF_OCF
Debt as % of DCF PV
25.7%
Public economic interest
99.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.